Literature DB >> 29519321

Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression.

Nesa Jafari1, Sonbol Nazeri2, Sattar Tahmasebi Enferadi3.   

Abstract

BACKGROUND: Use of pharmaceutical agent for breast cancer chemotherapy is an interesting method that induces cells death by different way, such as apoptosis. Parthenolide is the main compound in feverfew that has been used to cure migraine and rheumatoid arthritis for long time. Parthenolide has been predominately investigated as inducer of apoptosis in human cancer cells.
PURPOSE: We examined the expression of vimentin and Elongation factor α - 1 as breast cancer biomarkers in MCF7 cells exposure to Parthenolide.
METHOD: In this study, we investigated the antitumor mechanism of Parthenolide on the human breast cancer cell line MCF7, using SEM, flow cytometry and proteomics techniques. RESULT: Comparative proteome analyses are shown Elongation factor1-α and vimentin was suppressed in response to Parthenolide treatment.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Metastasis; Parthenolide; Vimentin and Elongation factor α − 1

Mesh:

Substances:

Year:  2018        PMID: 29519321     DOI: 10.1016/j.phymed.2018.01.022

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  8 in total

1.  Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.

Authors:  Charles A Berdan; Raymond Ho; Haley S Lehtola; Milton To; Xirui Hu; Tucker R Huffman; Yana Petri; Chad R Altobelli; Sasha G Demeulenaere; James A Olzmann; Thomas J Maimone; Daniel K Nomura
Journal:  Cell Chem Biol       Date:  2019-05-09       Impact factor: 8.116

Review 2.  Natural and Synthetic Lactones Possessing Antitumor Activities.

Authors:  Younghoon Kim; Sandip Sengupta; Taebo Sim
Journal:  Int J Mol Sci       Date:  2021-01-21       Impact factor: 6.208

3.  Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhihui Zhang; Kai Zhang; Mi Zhang; Xiaomin Zhang; Rongxin Zhang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

4.  Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.

Authors:  Xin Jin; Xinyue Lu; Zhenhai Zhang; Huixia Lv
Journal:  Int J Nanomedicine       Date:  2020-05-05

5.  Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells.

Authors:  Shi Mao Zhu; Yong Ran Park; Seung Yong Seo; In Hee Kim; Soo Teik Lee; Sang Wook Kim
Journal:  Intest Res       Date:  2019-08-23

Review 6.  Plants as a Source of Anticancer Agents: From Bench to Bedside.

Authors:  Wamidh H Talib; Safa Daoud; Asma Ismail Mahmod; Reem Ali Hamed; Dima Awajan; Sara Feras Abuarab; Lena Hisham Odeh; Samar Khater; Lina T Al Kury
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

Review 7.  Combination Anticancer Therapies Using Selected Phytochemicals.

Authors:  Wamidh H Talib; Dima Awajan; Reem Ali Hamed; Aya O Azzam; Asma Ismail Mahmod; Intisar Hadi Al-Yasari
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

8.  Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner.

Authors:  Yao-Jiang Liu; Bo Tang; Feng-Chao Wang; Li Tang; Yuan-Yuan Lei; Ya Luo; Sheng-Jie Huang; Min Yang; Ling-Yi Wu; Wei Wang; Shuang Liu; Shi-Ming Yang; Xiao-Yan Zhao
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.